Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Apr;146(4):785–811.

Etiology and pathogenesis of prion diseases.

S J DeArmond 1, S B Prusiner 1
PMCID: PMC1869256  PMID: 7717447

Full text

PDF
785

Images in this article

789Figure 2
on p.789
790Figure 3
on p.790
794Figure 4
on p.794
796Figure 5
on p.796
797Figure 6
on p.797
798Figure 7
on p.798
799Figure 8
on p.799
800Figure 9
on p.800

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper T., Cramp W. A., Haig D. A., Clarke M. C. Does the agent of scrapie replicate without nucleic acid? Nature. 1967 May 20;214(5090):764–766. doi: 10.1038/214764a0. [DOI] [PubMed] [Google Scholar]
  2. Alper T., Haig D. A., Clarke M. C. The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun. 1966 Feb 3;22(3):278–284. doi: 10.1016/0006-291x(66)90478-5. [DOI] [PubMed] [Google Scholar]
  3. Alper T., Haig D. A., Clarke M. C. The scrapie agent: evidence against its dependence for replication on intrinsic nucleic acid. J Gen Virol. 1978 Dec;41(3):503–516. doi: 10.1099/0022-1317-41-3-503. [DOI] [PubMed] [Google Scholar]
  4. Askanas V., Bilak M., Engel W. K., Alvarez R. B., Tomé F., Leclerc A. Prion protein is abnormally accumulated in inclusion-body myositis. Neuroreport. 1993 Oct 25;5(1):25–28. doi: 10.1097/00001756-199310000-00006. [DOI] [PubMed] [Google Scholar]
  5. Askanas V., Bilak M., Engel W. K., Leclerc A., Tomé F. Prion protein is strongly immunolocalized at the postsynaptic domain of human normal neuromuscular junctions. Neurosci Lett. 1993 Sep 3;159(1-2):111–114. doi: 10.1016/0304-3940(93)90811-x. [DOI] [PubMed] [Google Scholar]
  6. Askanas V., Mirabella M., Engel W. K., Alvarez R. B., Weisgraber K. H. Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases. Lancet. 1994 Feb 5;343(8893):364–365. doi: 10.1016/s0140-6736(94)91208-4. [DOI] [PubMed] [Google Scholar]
  7. BECK E., DANIEL P. M., PARRY H. B. DEGENERATION OF THE CEREBELLAR AND HYPOTHALAMONEUROHYPOPHYSIAL SYSTEMS IN SHEEP WITH SCRAPIE; AND ITS RELATIONSHIP TO HUMAN SYSTEM DEGENERATIONS. Brain. 1964 Mar;87:153–176. doi: 10.1093/brain/87.1.153. [DOI] [PubMed] [Google Scholar]
  8. BOSANQUET F. D., DANIEL P. M., PARRY H. B. Myopathy in sheep; its relationship to scrapie and to dermatomyositis and muscular dystrophy. Lancet. 1956 Oct 13;271(6946):737–746. doi: 10.1016/s0140-6736(56)90957-6. [DOI] [PubMed] [Google Scholar]
  9. Beck E., Daniel P. M., Matthews W. B., Stevens D. L., Alpers M. P., Asher D. M., Gajdusek D. C., Gibbs C. J., Jr Creutzfeldt-Jakob disease. The neuropathology of a transmission experiment. Brain. 1969;92(4):699–716. doi: 10.1093/brain/92.4.699. [DOI] [PubMed] [Google Scholar]
  10. Bellinger-Kawahara C. G., Kempner E., Groth D., Gabizon R., Prusiner S. B. Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da. Virology. 1988 Jun;164(2):537–541. doi: 10.1016/0042-6822(88)90569-7. [DOI] [PubMed] [Google Scholar]
  11. Bellinger-Kawahara C., Cleaver J. E., Diener T. O., Prusiner S. B. Purified scrapie prions resist inactivation by UV irradiation. J Virol. 1987 Jan;61(1):159–166. doi: 10.1128/jvi.61.1.159-166.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bellinger-Kawahara C., Diener T. O., McKinley M. P., Groth D. F., Smith D. R., Prusiner S. B. Purified scrapie prions resist inactivation by procedures that hydrolyze, modify, or shear nucleic acids. Virology. 1987 Sep;160(1):271–274. doi: 10.1016/0042-6822(87)90072-9. [DOI] [PubMed] [Google Scholar]
  13. Bendheim P. E., Bockman J. M., McKinley M. P., Kingsbury D. T., Prusiner S. B. Scrapie and Creutzfeldt-Jakob disease prion proteins share physical properties and antigenic determinants. Proc Natl Acad Sci U S A. 1985 Feb;82(4):997–1001. doi: 10.1073/pnas.82.4.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Berger J. R., David N. J. Creutzfeldt-Jakob disease in a physician: a review of the disorder in health care workers. Neurology. 1993 Jan;43(1):205–206. doi: 10.1212/wnl.43.1_part_1.205. [DOI] [PubMed] [Google Scholar]
  15. Bernoulli C., Siegfried J., Baumgartner G., Regli F., Rabinowicz T., Gajdusek D. C., Gibbs C. J., Jr Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet. 1977 Feb 26;1(8009):478–479. doi: 10.1016/s0140-6736(77)91958-4. [DOI] [PubMed] [Google Scholar]
  16. Billette de Villemeur T. B., Beauvais P., Gourmelen M., Richardet J. M. Creutzfeldt-Jakob disease in children treated with growth hormone. Lancet. 1991 Apr 6;337(8745):864–865. doi: 10.1016/0140-6736(91)92583-n. [DOI] [PubMed] [Google Scholar]
  17. Bockman J. M., Kingsbury D. T., McKinley M. P., Bendheim P. E., Prusiner S. B. Creutzfeldt-Jakob disease prion proteins in human brains. N Engl J Med. 1985 Jan 10;312(2):73–78. doi: 10.1056/NEJM198501103120202. [DOI] [PubMed] [Google Scholar]
  18. Bolton D. C., McKinley M. P., Prusiner S. B. Identification of a protein that purifies with the scrapie prion. Science. 1982 Dec 24;218(4579):1309–1311. doi: 10.1126/science.6815801. [DOI] [PubMed] [Google Scholar]
  19. Bolton D. C., Meyer R. K., Prusiner S. B. Scrapie PrP 27-30 is a sialoglycoprotein. J Virol. 1985 Feb;53(2):596–606. doi: 10.1128/jvi.53.2.596-606.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Borchelt D. R., Koliatsos V. E., Guarnieri M., Pardo C. A., Sisodia S. S., Price D. L. Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous systems. J Biol Chem. 1994 May 20;269(20):14711–14714. [PubMed] [Google Scholar]
  21. Borchelt D. R., Scott M., Taraboulos A., Stahl N., Prusiner S. B. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol. 1990 Mar;110(3):743–752. doi: 10.1083/jcb.110.3.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Brown P., Cervenáková L., Goldfarb L. G., McCombie W. R., Rubenstein R., Will R. G., Pocchiari M., Martinez-Lage J. F., Scalici C., Masullo C. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology. 1994 Feb;44(2):291–293. doi: 10.1212/wnl.44.2.291. [DOI] [PubMed] [Google Scholar]
  23. Brown P., Coker-Vann M., Pomeroy K., Franko M., Asher D. M., Gibbs C. J., Jr, Gajdusek D. C. Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med. 1986 Feb 27;314(9):547–551. doi: 10.1056/NEJM198602273140904. [DOI] [PubMed] [Google Scholar]
  24. Brown P., Gibbs C. J., Jr, Rodgers-Johnson P., Asher D. M., Sulima M. P., Bacote A., Goldfarb L. G., Gajdusek D. C. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol. 1994 May;35(5):513–529. doi: 10.1002/ana.410350504. [DOI] [PubMed] [Google Scholar]
  25. Brown P., Preece M. A., Will R. G. "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet. 1992 Jul 4;340(8810):24–27. doi: 10.1016/0140-6736(92)92431-e. [DOI] [PubMed] [Google Scholar]
  26. Brown P., Rodgers-Johnson P., Cathala F., Gibbs C. J., Jr, Gajdusek D. C. Creutzfeldt-Jakob disease of long duration: clinicopathological characteristics, transmissibility, and differential diagnosis. Ann Neurol. 1984 Sep;16(3):295–304. doi: 10.1002/ana.410160305. [DOI] [PubMed] [Google Scholar]
  27. Brown P. Virus sterility for human growth hormone. Lancet. 1985 Sep 28;2(8457):729–730. doi: 10.1016/s0140-6736(85)92971-x. [DOI] [PubMed] [Google Scholar]
  28. Bruce M. E., Dickinson A. G. Biological evidence that scrapie agent has an independent genome. J Gen Virol. 1987 Jan;68(Pt 1):79–89. doi: 10.1099/0022-1317-68-1-79. [DOI] [PubMed] [Google Scholar]
  29. Bruce M. E., McBride P. A., Farquhar C. F. Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie. Neurosci Lett. 1989 Jul 17;102(1):1–6. doi: 10.1016/0304-3940(89)90298-x. [DOI] [PubMed] [Google Scholar]
  30. Buchanan C. R., Preece M. A., Milner R. D. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ. 1991 Apr 6;302(6780):824–828. doi: 10.1136/bmj.302.6780.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Buyukmihci N., Rorvik M., Marsh R. F. Replication of the scrapie agent in ocular neural tissues. Proc Natl Acad Sci U S A. 1980 Feb;77(2):1169–1171. doi: 10.1073/pnas.77.2.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Büeler H., Aguzzi A., Sailer A., Greiner R. A., Autenried P., Aguet M., Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell. 1993 Jul 2;73(7):1339–1347. doi: 10.1016/0092-8674(93)90360-3. [DOI] [PubMed] [Google Scholar]
  33. Büeler H., Fischer M., Lang Y., Bluethmann H., Lipp H. P., DeArmond S. J., Prusiner S. B., Aguet M., Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 1992 Apr 16;356(6370):577–582. doi: 10.1038/356577a0. [DOI] [PubMed] [Google Scholar]
  34. Carlson G. A., Kingsbury D. T., Goodman P. A., Coleman S., Marshall S. T., DeArmond S., Westaway D., Prusiner S. B. Linkage of prion protein and scrapie incubation time genes. Cell. 1986 Aug 15;46(4):503–511. doi: 10.1016/0092-8674(86)90875-5. [DOI] [PubMed] [Google Scholar]
  35. Caselli R. J., Windebank A. J., Petersen R. C., Komori T., Parisi J. E., Okazaki H., Kokmen E., Iverson R., Dinapoli R. P., Graff-Radford N. R. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol. 1993 Feb;33(2):200–207. doi: 10.1002/ana.410330210. [DOI] [PubMed] [Google Scholar]
  36. Caughey B. W., Dong A., Bhat K. S., Ernst D., Hayes S. F., Caughey W. S. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry. 1991 Aug 6;30(31):7672–7680. doi: 10.1021/bi00245a003. [DOI] [PubMed] [Google Scholar]
  37. Caughey B., Race R. E., Ernst D., Buchmeier M. J., Chesebro B. Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol. 1989 Jan;63(1):175–181. doi: 10.1128/jvi.63.1.175-181.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Cochius J. I., Burns R. J., Blumbergs P. C., Mack K., Alderman C. P. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust N Z J Med. 1990 Aug;20(4):592–593. doi: 10.1111/j.1445-5994.1990.tb01322.x. [DOI] [PubMed] [Google Scholar]
  39. Cochius J. I., Hyman N., Esiri M. M. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin: a second case. J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):1094–1095. doi: 10.1136/jnnp.55.11.1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Cohen F. E., Pan K. M., Huang Z., Baldwin M., Fletterick R. J., Prusiner S. B. Structural clues to prion replication. Science. 1994 Apr 22;264(5158):530–531. doi: 10.1126/science.7909169. [DOI] [PubMed] [Google Scholar]
  41. Collinge J., Palmer M. S., Dryden A. J. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet. 1991 Jun 15;337(8755):1441–1442. doi: 10.1016/0140-6736(91)93128-v. [DOI] [PubMed] [Google Scholar]
  42. Croxson M., Brown P., Synek B., Harrington M. G., Frith R., Clover G., Wilson J., Gajdusek D. C. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand. Neurology. 1988 Jul;38(7):1128–1130. doi: 10.1212/wnl.38.7.1128. [DOI] [PubMed] [Google Scholar]
  43. Davanipour Z., Goodman L., Alter M., Sobel E., Asher D., Gajdusek D. C. Possible modes of transmission of Creutzfeldt-Jakob disease. N Engl J Med. 1984 Dec 13;311(24):1582–1583. doi: 10.1056/NEJM198412133112422. [DOI] [PubMed] [Google Scholar]
  44. DeArmond S. J., McKinley M. P., Barry R. A., Braunfeld M. B., McColloch J. R., Prusiner S. B. Identification of prion amyloid filaments in scrapie-infected brain. Cell. 1985 May;41(1):221–235. doi: 10.1016/0092-8674(85)90076-5. [DOI] [PubMed] [Google Scholar]
  45. DeArmond S. J., Mobley W. C., DeMott D. L., Barry R. A., Beckstead J. H., Prusiner S. B. Changes in the localization of brain prion proteins during scrapie infection. Neurology. 1987 Aug;37(8):1271–1280. doi: 10.1212/wnl.37.8.1271. [DOI] [PubMed] [Google Scholar]
  46. DeArmond S. J., Prusiner S. B. The neurochemistry of prion diseases. J Neurochem. 1993 Nov;61(5):1589–1601. doi: 10.1111/j.1471-4159.1993.tb09792.x. [DOI] [PubMed] [Google Scholar]
  47. DeArmond S. J., Yang S. L., Lee A., Bowler R., Taraboulos A., Groth D., Prusiner S. B. Three scrapie prion isolates exhibit different accumulation patterns of the prion protein scrapie isoform. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6449–6453. doi: 10.1073/pnas.90.14.6449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Deslys J. P., Marcé D., Dormont D. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J Gen Virol. 1994 Jan;75(Pt 1):23–27. doi: 10.1099/0022-1317-75-1-23. [DOI] [PubMed] [Google Scholar]
  49. Dickinson A. G., Meikle V. M., Fraser H. Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. J Comp Pathol. 1968 Jul;78(3):293–299. doi: 10.1016/0021-9975(68)90005-4. [DOI] [PubMed] [Google Scholar]
  50. Dickinson A. G., Meikle V. M. Host-genotype and agent effects in scrapie incubation: change in allelic interaction with different strains of agent. Mol Gen Genet. 1971;112(1):73–79. doi: 10.1007/BF00266934. [DOI] [PubMed] [Google Scholar]
  51. Dickinson A. G., Outram G. W. Genetic aspects of unconventional virus infections: the basis of the virino hypothesis. Ciba Found Symp. 1988;135:63–83. doi: 10.1002/9780470513613.ch5. [DOI] [PubMed] [Google Scholar]
  52. Dlouhy S. R., Hsiao K., Farlow M. R., Foroud T., Conneally P. M., Johnson P., Prusiner S. B., Hodes M. E., Ghetti B. Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene. Nat Genet. 1992 Apr;1(1):64–67. doi: 10.1038/ng0492-64. [DOI] [PubMed] [Google Scholar]
  53. Doh-ura K., Kitamoto T., Sakaki Y., Tateishi J. CJD discrepancy. Nature. 1991 Oct 31;353(6347):801–802. doi: 10.1038/353801b0. [DOI] [PubMed] [Google Scholar]
  54. Doh-ura K., Tateishi J., Sasaki H., Kitamoto T., Sakaki Y. Pro----leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun. 1989 Sep 15;163(2):974–979. doi: 10.1016/0006-291x(89)92317-6. [DOI] [PubMed] [Google Scholar]
  55. Duffy P., Wolf J., Collins G., DeVoe A. G., Streeten B., Cowen D. Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med. 1974 Mar 21;290(12):692–693. [PubMed] [Google Scholar]
  56. Ellis C. J., Katifi H., Weller R. O. A further British case of growth hormone induced Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1200–1202. doi: 10.1136/jnnp.55.12.1200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. FRIEDE R. L., DEJONG R. N. NEURONAL ENZYMATIC FAILURE IN CREUTZFELDT-JAKOB DISEASE; A FAMILIAL STUDY. Arch Neurol. 1964 Feb;10:181–195. doi: 10.1001/archneur.1964.00460140067009. [DOI] [PubMed] [Google Scholar]
  58. Fradkin J. E., Schonberger L. B., Mills J. L., Gunn W. J., Piper J. M., Wysowski D. K., Thomson R., Durako S., Brown P. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA. 1991 Feb 20;265(7):880–884. [PubMed] [Google Scholar]
  59. GAJDUSEK D. C., ZIGAS V. Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population. N Engl J Med. 1957 Nov 14;257(20):974–978. doi: 10.1056/NEJM195711142572005. [DOI] [PubMed] [Google Scholar]
  60. GAJDUSEK D. C., ZIGAS V. Kuru; clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the Eastern Highlands of New Guinea. Am J Med. 1959 Mar;26(3):442–469. doi: 10.1016/0002-9343(59)90251-7. [DOI] [PubMed] [Google Scholar]
  61. Gabizon R., Rosenmann H., Meiner Z., Kahana I., Kahana E., Shugart Y., Ott J., Prusiner S. B. Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). Am J Hum Genet. 1993 Oct;53(4):828–835. [PMC free article] [PubMed] [Google Scholar]
  62. Gajdusek D. C., Gibbs C. J., Jr, Asher D. M., Brown P., Diwan A., Hoffman P., Nemo G., Rohwer R., White L. Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med. 1977 Dec 8;297(23):1253–1258. doi: 10.1056/NEJM197712082972304. [DOI] [PubMed] [Google Scholar]
  63. Gajdusek D. C. Unconventional viruses and the origin and disappearance of kuru. Science. 1977 Sep 2;197(4307):943–960. doi: 10.1126/science.142303. [DOI] [PubMed] [Google Scholar]
  64. Gasset M., Baldwin M. A., Fletterick R. J., Prusiner S. B. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):1–5. doi: 10.1073/pnas.90.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Gasset M., Baldwin M. A., Lloyd D. H., Gabriel J. M., Holtzman D. M., Cohen F., Fletterick R., Prusiner S. B. Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10940–10944. doi: 10.1073/pnas.89.22.10940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Ghetti B., Tagliavini F., Masters C. L., Beyreuther K., Giaccone G., Verga L., Farlow M. R., Conneally P. M., Dlouhy S. R., Azzarelli B. Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology. 1989 Nov;39(11):1453–1461. doi: 10.1212/wnl.39.11.1453. [DOI] [PubMed] [Google Scholar]
  67. Gibbs C. J., Jr, Asher D. M., Brown P. W., Fradkin J. E., Gajdusek D. C. Creutzfeldt-Jakob disease infectivity of growth hormone derived from human pituitary glands. N Engl J Med. 1993 Feb 4;328(5):358–359. doi: 10.1056/NEJM199302043280520. [DOI] [PubMed] [Google Scholar]
  68. Gibbs C. J., Jr, Gajdusek D. C., Asher D. M., Alpers M. P., Beck E., Daniel P. M., Matthews W. B. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science. 1968 Jul 26;161(3839):388–389. doi: 10.1126/science.161.3839.388. [DOI] [PubMed] [Google Scholar]
  69. Gibbs C. J., Jr, Joy A., Heffner R., Franko M., Miyazaki M., Asher D. M., Parisi J. E., Brown P. W., Gajdusek D. C. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med. 1985 Sep 19;313(12):734–738. doi: 10.1056/NEJM198509193131207. [DOI] [PubMed] [Google Scholar]
  70. Godec M. S., Asher D. M., Kozachuk W. E., Masters C. L., Rubi J. U., Payne J. A., Rubi-Villa D. J., Wagner E. E., Rapoport S. I., Schapiro M. B. Blood buffy coat from Alzheimer's disease patients and their relatives does not transmit spongiform encephalopathy to hamsters. Neurology. 1994 Jun;44(6):1111–1115. doi: 10.1212/wnl.44.6.1111. [DOI] [PubMed] [Google Scholar]
  71. Goldfarb L. G., Brown P., Goldgaber D., Asher D. M., Rubenstein R., Brown W. T., Piccardo P., Kascsak R. J., Boellaard J. W., Gajdusek D. C. Creutzfeldt-Jakob disease and kuru patients lack a mutation consistently found in the Gerstmann-Sträussler-Scheinker syndrome. Exp Neurol. 1990 Jun;108(3):247–250. doi: 10.1016/0014-4886(90)90130-k. [DOI] [PubMed] [Google Scholar]
  72. Goldfarb L. G., Brown P., Haltia M., Cathala F., McCombie W. R., Kovanen J., Cervenáková L., Goldin L., Nieto A., Godec M. S. Creutzfeldt-Jakob disease cosegregates with the codon 178Asn PRNP mutation in families of European origin. Ann Neurol. 1992 Mar;31(3):274–281. doi: 10.1002/ana.410310308. [DOI] [PubMed] [Google Scholar]
  73. Goldfarb L. G., Brown P., McCombie W. R., Goldgaber D., Swergold G. D., Wills P. R., Cervenakova L., Baron H., Gibbs C. J., Jr, Gajdusek D. C. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10926–10930. doi: 10.1073/pnas.88.23.10926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Goldfarb L. G., Haltia M., Brown P., Nieto A., Kovanen J., McCombie W. R., Trapp S., Gajdusek D. C. New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred. Lancet. 1991 Feb 16;337(8738):425–425. doi: 10.1016/0140-6736(91)91198-4. [DOI] [PubMed] [Google Scholar]
  75. Goldfarb L. G., Mitrová E., Brown P., Toh B. K., Gajdusek D. C. Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet. 1990 Aug 25;336(8713):514–515. doi: 10.1016/0140-6736(90)92073-q. [DOI] [PubMed] [Google Scholar]
  76. Goldgaber D., Goldfarb L. G., Brown P., Asher D. M., Brown W. T., Lin S., Teener J. W., Feinstone S. M., Rubenstein R., Kascsak R. J. Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol. 1989 Nov;106(2):204–206. doi: 10.1016/0014-4886(89)90095-2. [DOI] [PubMed] [Google Scholar]
  77. Goudsmit J., Morrow C. H., Asher D. M., Yanagihara R. T., Masters C. L., Gibbs C. J., Jr, Gajdusek D. C. Evidence for and against the transmissibility of Alzheimer disease. Neurology. 1980 Sep;30(9):945–950. doi: 10.1212/wnl.30.9.945. [DOI] [PubMed] [Google Scholar]
  78. HULLAND T. J. The skeletal muscle of sheep affected with scrapie. J Comp Pathol. 1958 Apr;68(2):264–274. doi: 10.1016/s0368-1742(58)80027-2. [DOI] [PubMed] [Google Scholar]
  79. Hardy J. Prion dimers: a deadly duo? Trends Neurosci. 1991 Oct;14(10):423–424. doi: 10.1016/0166-2236(91)90038-v. [DOI] [PubMed] [Google Scholar]
  80. Healy D. L., Evans J. Creutzfeldt-Jakob disease after pituitary gonadotrophins. BMJ. 1993 Aug 28;307(6903):517–518. doi: 10.1136/bmj.307.6903.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Hecker R., Taraboulos A., Scott M., Pan K. M., Yang S. L., Torchia M., Jendroska K., DeArmond S. J., Prusiner S. B. Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev. 1992 Jul;6(7):1213–1228. doi: 10.1101/gad.6.7.1213. [DOI] [PubMed] [Google Scholar]
  82. Hsiao K. K., Groth D., Scott M., Yang S. L., Serban H., Rapp D., Foster D., Torchia M., Dearmond S. J., Prusiner S. B. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9126–9130. doi: 10.1073/pnas.91.19.9126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Hsiao K. K., Scott M., Foster D., Groth D. F., DeArmond S. J., Prusiner S. B. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science. 1990 Dec 14;250(4987):1587–1590. doi: 10.1126/science.1980379. [DOI] [PubMed] [Google Scholar]
  84. Hsiao K., Baker H. F., Crow T. J., Poulter M., Owen F., Terwilliger J. D., Westaway D., Ott J., Prusiner S. B. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature. 1989 Mar 23;338(6213):342–345. doi: 10.1038/338342a0. [DOI] [PubMed] [Google Scholar]
  85. Hsiao K., Dlouhy S. R., Farlow M. R., Cass C., Da Costa M., Conneally P. M., Hodes M. E., Ghetti B., Prusiner S. B. Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nat Genet. 1992 Apr;1(1):68–71. doi: 10.1038/ng0492-68. [DOI] [PubMed] [Google Scholar]
  86. Hsiao K., Meiner Z., Kahana E., Cass C., Kahana I., Avrahami D., Scarlato G., Abramsky O., Prusiner S. B., Gabizon R. Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med. 1991 Apr 18;324(16):1091–1097. doi: 10.1056/NEJM199104183241604. [DOI] [PubMed] [Google Scholar]
  87. Huang Z., Gabriel J. M., Baldwin M. A., Fletterick R. J., Prusiner S. B., Cohen F. E. Proposed three-dimensional structure for the cellular prion protein. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7139–7143. doi: 10.1073/pnas.91.15.7139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. JACOB H., PYRKOSCH W., STRUBE H. Die erbliche Form der Creutzfeldt-Jakobschen Krankheit (Familie Backer). Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1950;184(7):653–674. doi: 10.1007/BF00344941. [DOI] [PubMed] [Google Scholar]
  89. Jakob-Creutzfeldt disease associated with cadaveric dura. J Neurosurg. 1987 Jul;67(1):149–150. doi: 10.3171/jns.1987.67.1.0149. [DOI] [PubMed] [Google Scholar]
  90. Jendroska K., Heinzel F. P., Torchia M., Stowring L., Kretzschmar H. A., Kon A., Stern A., Prusiner S. B., DeArmond S. J. Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology. 1991 Sep;41(9):1482–1490. doi: 10.1212/wnl.41.9.1482. [DOI] [PubMed] [Google Scholar]
  91. Jones R. L., Benker G., Salacinski P. R., Lloyd T. J., Lowry P. J. Large-scale preparation of highly purified pyrogen-free human growth hormone for clinical use. J Endocrinol. 1979 Jul;82(1):77–86. doi: 10.1677/joe.0.0820077. [DOI] [PubMed] [Google Scholar]
  92. Kellings K., Meyer N., Mirenda C., Prusiner S. B., Riesner D. Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis. J Gen Virol. 1992 Apr;73(Pt 4):1025–1029. doi: 10.1099/0022-1317-73-4-1025. [DOI] [PubMed] [Google Scholar]
  93. Kitamoto T., Iizuka R., Tateishi J. An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun. 1993 Apr 30;192(2):525–531. doi: 10.1006/bbrc.1993.1447. [DOI] [PubMed] [Google Scholar]
  94. Kitamoto T., Ohta M., Doh-ura K., Hitoshi S., Terao Y., Tateishi J. Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun. 1993 Mar 15;191(2):709–714. doi: 10.1006/bbrc.1993.1275. [DOI] [PubMed] [Google Scholar]
  95. Kitamoto T., Tateishi J. Human prion diseases with variant prion protein. Philos Trans R Soc Lond B Biol Sci. 1994 Mar 29;343(1306):391–398. doi: 10.1098/rstb.1994.0034. [DOI] [PubMed] [Google Scholar]
  96. Kitamoto T., Tateishi J., Tashima T., Takeshita I., Barry R. A., DeArmond S. J., Prusiner S. B. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann Neurol. 1986 Aug;20(2):204–208. doi: 10.1002/ana.410200205. [DOI] [PubMed] [Google Scholar]
  97. Koch T. K., Berg B. O., De Armond S. J., Gravina R. F. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. N Engl J Med. 1985 Sep 19;313(12):731–733. doi: 10.1056/NEJM198509193131206. [DOI] [PubMed] [Google Scholar]
  98. Kondo K., Kuroiwa Y. A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol. 1982 Apr;11(4):377–381. doi: 10.1002/ana.410110410. [DOI] [PubMed] [Google Scholar]
  99. Kretzschmar H. A., Prusiner S. B., Stowring L. E., DeArmond S. J. Scrapie prion proteins are synthesized in neurons. Am J Pathol. 1986 Jan;122(1):1–5. [PMC free article] [PubMed] [Google Scholar]
  100. Kretzschmar H. A., Stowring L. E., Westaway D., Stubblebine W. H., Prusiner S. B., Dearmond S. J. Molecular cloning of a human prion protein cDNA. DNA. 1986 Aug;5(4):315–324. doi: 10.1089/dna.1986.5.315. [DOI] [PubMed] [Google Scholar]
  101. Kuzuhara S., Kanazawa I., Sasaki H., Nakanishi T., Shimamura K. Gerstmann-Sträussler-Scheinker's disease. Ann Neurol. 1983 Aug;14(2):216–225. doi: 10.1002/ana.410140208. [DOI] [PubMed] [Google Scholar]
  102. Laplanche J. L., Chatelain J., Launay J. M., Gazengel C., Vidaud M. Deletion in prion protein gene in a Moroccan family. Nucleic Acids Res. 1990 Nov 25;18(22):6745–6745. doi: 10.1093/nar/18.22.6745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Laszlo L., Lowe J., Self T., Kenward N., Landon M., McBride T., Farquhar C., McConnell I., Brown J., Hope J. Lysosomes as key organelles in the pathogenesis of prion encephalopathies. J Pathol. 1992 Apr;166(4):333–341. doi: 10.1002/path.1711660404. [DOI] [PubMed] [Google Scholar]
  104. Macario M. E., Vaisman M., Buescu A., Moura Neto V., Araujo H. M., Chagas C. Pituitary growth hormone and Creutzfeldt-Jakob disease. BMJ. 1991 May 11;302(6785):1149–1149. doi: 10.1136/bmj.302.6785.1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Manuelidis E. E., Manuelidis L. A transmissible Creutzfeldt-Jakob disease-like agent is prevalent in the human population. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7724–7728. doi: 10.1073/pnas.90.16.7724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Manuelidis E. E., de Figueiredo J. M., Kim J. H., Fritch W. W., Manuelidis L. Transmission studies from blood of Alzheimer disease patients and healthy relatives. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4898–4901. doi: 10.1073/pnas.85.13.4898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Martínez-Lage J. F., Sola J., Poza M., Esteban J. A. Pediatric Creutzfeldt-Jakob disease: probable transmission by a dural graft. Childs Nerv Syst. 1993 Jul;9(4):239–242. doi: 10.1007/BF00303577. [DOI] [PubMed] [Google Scholar]
  108. Marzewski D. J., Towfighi J., Harrington M. G., Merril C. R., Brown P. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case. Neurology. 1988 Jul;38(7):1131–1133. doi: 10.1212/wnl.38.7.1131. [DOI] [PubMed] [Google Scholar]
  109. Masters C. L., Gajdusek D. C., Gibbs C. J., Jr Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain. 1981 Sep;104(3):559–588. doi: 10.1093/brain/104.3.559. [DOI] [PubMed] [Google Scholar]
  110. Masters C. L., Richardson E. P., Jr Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain. 1978 Jun;101(2):333–344. doi: 10.1093/brain/101.2.333. [DOI] [PubMed] [Google Scholar]
  111. Masullo C., Pocchiari M., Macchi G., Alema G., Piazza G., Panzera M. A. Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J Neurosurg. 1989 Dec;71(6):954–955. doi: 10.3171/jns.1989.71.6.0954. [DOI] [PubMed] [Google Scholar]
  112. McKinley M. P., Bolton D. C., Prusiner S. B. A protease-resistant protein is a structural component of the scrapie prion. Cell. 1983 Nov;35(1):57–62. doi: 10.1016/0092-8674(83)90207-6. [DOI] [PubMed] [Google Scholar]
  113. McKinley M. P., Masiarz F. R., Isaacs S. T., Hearst J. E., Prusiner S. B. Resistance of the scrapie agent to inactivation by psoralens. Photochem Photobiol. 1983 May;37(5):539–545. doi: 10.1111/j.1751-1097.1983.tb04515.x. [DOI] [PubMed] [Google Scholar]
  114. McKinley M. P., Taraboulos A., Kenaga L., Serban D., Stieber A., DeArmond S. J., Prusiner S. B., Gonatas N. Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest. 1991 Dec;65(6):622–630. [PubMed] [Google Scholar]
  115. Medori R., Montagna P., Tritschler H. J., LeBlanc A., Cortelli P., Tinuper P., Lugaresi E., Gambetti P. Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology. 1992 Mar;42(3 Pt 1):669–670. doi: 10.1212/wnl.42.3.669. [DOI] [PubMed] [Google Scholar]
  116. Medori R., Tritschler H. J., LeBlanc A., Villare F., Manetto V., Chen H. Y., Xue R., Leal S., Montagna P., Cortelli P. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med. 1992 Feb 13;326(7):444–449. doi: 10.1056/NEJM199202133260704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Meyer N., Rosenbaum V., Schmidt B., Gilles K., Mirenda C., Groth D., Prusiner S. B., Riesner D. Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids. J Gen Virol. 1991 Jan;72(Pt 1):37–49. doi: 10.1099/0022-1317-72-1-37. [DOI] [PubMed] [Google Scholar]
  118. Meyer R. K., McKinley M. P., Bowman K. A., Braunfeld M. B., Barry R. A., Prusiner S. B. Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2310–2314. doi: 10.1073/pnas.83.8.2310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Miyashita K., Inuzuka T., Kondo H., Saito Y., Fujita N., Matsubara N., Tanaka R., Hinokuma K., Ikuta F., Miyatake T. Creutzfeldt-Jakob disease in a patient with a cadaveric dural graft. Neurology. 1991 Jun;41(6):940–941. doi: 10.1212/wnl.41.6.940. [DOI] [PubMed] [Google Scholar]
  120. Miyazono M., Kitamoto T., Doh-ura K., Iwaki T., Tateishi J. Creutzfeldt-Jakob disease with codon 129 polymorphism (valine): a comparative study of patients with codon 102 point mutation or without mutations. Acta Neuropathol. 1992;84(4):349–354. doi: 10.1007/BF00227660. [DOI] [PubMed] [Google Scholar]
  121. Morita K., Kaiya H., Ikeda T., Namba M. Presenile dementia combined with amyotrophy: a review of 34 Japanese cases. Arch Gerontol Geriatr. 1987 Sep;6(3):263–277. doi: 10.1016/0167-4943(87)90026-4. [DOI] [PubMed] [Google Scholar]
  122. Muramoto T., Kitamoto T., Tateishi J., Goto I. The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease. Am J Pathol. 1992 Jun;140(6):1411–1420. [PMC free article] [PubMed] [Google Scholar]
  123. Neufeld M. Y., Josiphov J., Korczyn A. D. Demyelinating peripheral neuropathy in Creutzfeldt-Jakob disease. Muscle Nerve. 1992 Nov;15(11):1234–1239. doi: 10.1002/mus.880151103. [DOI] [PubMed] [Google Scholar]
  124. New M. I., Brown P., Temeck J. W., Owens C., Hedley-Whyte E. T., Richardson E. P. Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient. Neurology. 1988 Jul;38(7):1133–1134. doi: 10.1212/wnl.38.7.1133. [DOI] [PubMed] [Google Scholar]
  125. Nochlin D., Sumi S. M., Bird T. D., Snow A. D., Leventhal C. M., Beyreuther K., Masters C. L. Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Sträussler syndrome. Neurology. 1989 Jul;39(7):910–918. doi: 10.1212/wnl.39.7.910. [DOI] [PubMed] [Google Scholar]
  126. Oesch B., Westaway D., Wälchli M., McKinley M. P., Kent S. B., Aebersold R., Barry R. A., Tempst P., Teplow D. B., Hood L. E. A cellular gene encodes scrapie PrP 27-30 protein. Cell. 1985 Apr;40(4):735–746. doi: 10.1016/0092-8674(85)90333-2. [DOI] [PubMed] [Google Scholar]
  127. Owen F., Poulter M., Collinge J., Crow T. J. Codon 129 changes in the prion protein gene in Caucasians. Am J Hum Genet. 1990 Jun;46(6):1215–1216. [PMC free article] [PubMed] [Google Scholar]
  128. Owen F., Poulter M., Lofthouse R., Collinge J., Crow T. J., Risby D., Baker H. F., Ridley R. M., Hsiao K., Prusiner S. B. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet. 1989 Jan 7;1(8628):51–52. doi: 10.1016/s0140-6736(89)91713-3. [DOI] [PubMed] [Google Scholar]
  129. Owen F., Poulter M., Shah T., Collinge J., Lofthouse R., Baker H., Ridley R., McVey J., Crow T. J. An in-frame insertion in the prion protein gene in familial Creutzfeldt-Jakob disease. Brain Res Mol Brain Res. 1990 Apr;7(3):273–276. doi: 10.1016/0169-328x(90)90038-f. [DOI] [PubMed] [Google Scholar]
  130. Packer R. J., Cornblath D. R., Gonatas N. K., Bruno L. A., Asbury A. K. Creutzfeldt-Jakob disease in a 20-year-old woman. Neurology. 1980 May;30(5):492–496. doi: 10.1212/wnl.30.5.492. [DOI] [PubMed] [Google Scholar]
  131. Palmer M. S., Dryden A. J., Hughes J. T., Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 1991 Jul 25;352(6333):340–342. doi: 10.1038/352340a0. [DOI] [PubMed] [Google Scholar]
  132. Palmer M. S., Mahal S. P., Campbell T. A., Hill A. F., Sidle K. C., Laplanche J. L., Collinge J. Deletions in the prion protein gene are not associated with CJD. Hum Mol Genet. 1993 May;2(5):541–544. doi: 10.1093/hmg/2.5.541. [DOI] [PubMed] [Google Scholar]
  133. Pan K. M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R. J., Cohen F. E. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10962–10966. doi: 10.1073/pnas.90.23.10962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Pattison I. H. Fifty years with scrapie: a personal reminiscence. Vet Rec. 1988 Dec 24;123(26-27):661–666. [PubMed] [Google Scholar]
  135. Pearlman R. L., Towfighi J., Pezeshkpour G. H., Tenser R. B., Turel A. P. Clinical significance of types of cerebellar amyloid plaques in human spongiform encephalopathies. Neurology. 1988 Aug;38(8):1249–1254. doi: 10.1212/wnl.38.8.1249. [DOI] [PubMed] [Google Scholar]
  136. Petersen R. B., Tabaton M., Berg L., Schrank B., Torack R. M., Leal S., Julien J., Vital C., Deleplanque B., Pendlebury W. W. Analysis of the prion protein gene in thalamic dementia. Neurology. 1992 Oct;42(10):1859–1863. doi: 10.1212/wnl.42.10.1859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Pocchiari M., Peano S., Conz A., Eshkol A., Maillard F., Brown P., Gibbs C. J., Jr, Xi Y. G., Tenham-Fisher E., Macchi G. Combination ultrafiltration and 6 M urea treatment of human growth hormone effectively minimizes risk from potential Creutzfeldt-Jakob disease virus contamination. Horm Res. 1991;35(3-4):161–166. doi: 10.1159/000181894. [DOI] [PubMed] [Google Scholar]
  138. Poulter M., Baker H. F., Frith C. D., Leach M., Lofthouse R., Ridley R. M., Shah T., Owen F., Collinge J., Brown J. Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain. 1992 Jun;115(Pt 3):675–685. doi: 10.1093/brain/115.3.675. [DOI] [PubMed] [Google Scholar]
  139. Powell-Jackson J., Weller R. O., Kennedy P., Preece M. A., Whitcombe E. M., Newsom-Davis J. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet. 1985 Aug 3;2(8449):244–246. doi: 10.1016/s0140-6736(85)90292-2. [DOI] [PubMed] [Google Scholar]
  140. Prusiner S. B., Bolton D. C., Groth D. F., Bowman K. A., Cochran S. P., McKinley M. P. Further purification and characterization of scrapie prions. Biochemistry. 1982 Dec 21;21(26):6942–6950. doi: 10.1021/bi00269a050. [DOI] [PubMed] [Google Scholar]
  141. Prusiner S. B., Gajdusek C., Alpers M. P. Kuru with incubation periods exceeding two decades. Ann Neurol. 1982 Jul;12(1):1–9. doi: 10.1002/ana.410120102. [DOI] [PubMed] [Google Scholar]
  142. Prusiner S. B., Groth D. F., Bolton D. C., Kent S. B., Hood L. E. Purification and structural studies of a major scrapie prion protein. Cell. 1984 Aug;38(1):127–134. doi: 10.1016/0092-8674(84)90533-6. [DOI] [PubMed] [Google Scholar]
  143. Prusiner S. B., Groth D. F., Cochran S. P., McKinley M. P., Masiarz F. R. Gel electrophoresis and glass permeation chromatography of the hamster scrapie agent after enzymatic digestion and detergent extraction. Biochemistry. 1980 Oct 14;19(21):4892–4898. doi: 10.1021/bi00562a029. [DOI] [PubMed] [Google Scholar]
  144. Prusiner S. B., Groth D., Serban A., Koehler R., Foster D., Torchia M., Burton D., Yang S. L., DeArmond S. J. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10608–10612. doi: 10.1073/pnas.90.22.10608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Prusiner S. B., Hadlow W. J., Garfin D. E., Cochran S. P., Baringer J. R., Race R. E., Eklund C. M. Partial purification and evidence for multiple molecular forms of the scrapie agent. Biochemistry. 1978 Nov 14;17(23):4993–4999. doi: 10.1021/bi00616a021. [DOI] [PubMed] [Google Scholar]
  146. Prusiner S. B., Hsiao K. K. Human prion diseases. Ann Neurol. 1994 Apr;35(4):385–395. doi: 10.1002/ana.410350404. [DOI] [PubMed] [Google Scholar]
  147. Prusiner S. B., McKinley M. P., Bowman K. A., Bolton D. C., Bendheim P. E., Groth D. F., Glenner G. G. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell. 1983 Dec;35(2 Pt 1):349–358. doi: 10.1016/0092-8674(83)90168-x. [DOI] [PubMed] [Google Scholar]
  148. Prusiner S. B. Molecular biology of prion diseases. Science. 1991 Jun 14;252(5012):1515–1522. doi: 10.1126/science.1675487. [DOI] [PubMed] [Google Scholar]
  149. Prusiner S. B. Novel proteinaceous infectious particles cause scrapie. Science. 1982 Apr 9;216(4542):136–144. doi: 10.1126/science.6801762. [DOI] [PubMed] [Google Scholar]
  150. Prusiner S. B. Prions. Sci Am. 1984 Oct;251(4):50–59. doi: 10.1038/scientificamerican1084-50. [DOI] [PubMed] [Google Scholar]
  151. Prusiner S. B., Scott M., Foster D., Pan K. M., Groth D., Mirenda C., Torchia M., Yang S. L., Serban D., Carlson G. A. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell. 1990 Nov 16;63(4):673–686. doi: 10.1016/0092-8674(90)90134-z. [DOI] [PubMed] [Google Scholar]
  152. Prusiner S. B. Scrapie prions. Annu Rev Microbiol. 1989;43:345–374. doi: 10.1146/annurev.mi.43.100189.002021. [DOI] [PubMed] [Google Scholar]
  153. Prusiner S. B. The prion diseases. Sci Am. 1995 Jan;272(1):48-51, 54-7. doi: 10.1038/scientificamerican0195-48. [DOI] [PubMed] [Google Scholar]
  154. Puckett C., Concannon P., Casey C., Hood L. Genomic structure of the human prion protein gene. Am J Hum Genet. 1991 Aug;49(2):320–329. [PMC free article] [PubMed] [Google Scholar]
  155. Ridley R. M., Baker H. F. Occupational risk of Creutzfeldt-Jakob disease. Lancet. 1993 Mar 6;341(8845):641–642. doi: 10.1016/0140-6736(93)90413-b. [DOI] [PubMed] [Google Scholar]
  156. Ripoll L., Laplanche J. L., Salzmann M., Jouvet A., Planques B., Dussaucy M., Chatelain J., Beaudry P., Launay J. M. A new point mutation in the prion protein gene at codon 210 in Creutzfeldt-Jakob disease. Neurology. 1993 Oct;43(10):1934–1938. doi: 10.1212/wnl.43.10.1934. [DOI] [PubMed] [Google Scholar]
  157. Roberts G. W., Lofthouse R., Allsop D., Landon M., Kidd M., Prusiner S. B., Crow T. J. CNS amyloid proteins in neurodegenerative diseases. Neurology. 1988 Oct;38(10):1534–1540. doi: 10.1212/wnl.38.10.1534. [DOI] [PubMed] [Google Scholar]
  158. Rosenthal N. P., Keesey J., Crandall B., Brown W. J. Familial neurological disease associated with spongiform encephalopathy. Arch Neurol. 1976 Apr;33(4):252–259. doi: 10.1001/archneur.1976.00500040036005. [DOI] [PubMed] [Google Scholar]
  159. Safar J., Roller P. P., Gajdusek D. C., Gibbs C. J., Jr Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem. 1993 Sep 25;268(27):20276–20284. [PubMed] [Google Scholar]
  160. Salazar A. M., Masters C. L., Gajdusek D. C., Gibbs C. J., Jr Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt-Jakob disease. Ann Neurol. 1983 Jul;14(1):17–26. doi: 10.1002/ana.410140104. [DOI] [PubMed] [Google Scholar]
  161. Scott M., Foster D., Mirenda C., Serban D., Coufal F., Wälchli M., Torchia M., Groth D., Carlson G., DeArmond S. J. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell. 1989 Dec 1;59(5):847–857. doi: 10.1016/0092-8674(89)90608-9. [DOI] [PubMed] [Google Scholar]
  162. Scott M., Groth D., Foster D., Torchia M., Yang S. L., DeArmond S. J., Prusiner S. B. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell. 1993 Jun 4;73(5):979–988. doi: 10.1016/0092-8674(93)90275-u. [DOI] [PubMed] [Google Scholar]
  163. Serban D., Taraboulos A., DeArmond S. J., Prusiner S. B. Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology. 1990 Jan;40(1):110–117. doi: 10.1212/wnl.40.1.110. [DOI] [PubMed] [Google Scholar]
  164. Shyng S. L., Heuser J. E., Harris D. A. A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J Cell Biol. 1994 Jun;125(6):1239–1250. doi: 10.1083/jcb.125.6.1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Sparkes R. S., Simon M., Cohn V. H., Fournier R. E., Lem J., Klisak I., Heinzmann C., Blatt C., Lucero M., Mohandas T. Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7358–7362. doi: 10.1073/pnas.83.19.7358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Stahl N., Baldwin M. A., Hecker R., Pan K. M., Burlingame A. L., Prusiner S. B. Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. Biochemistry. 1992 Jun 2;31(21):5043–5053. doi: 10.1021/bi00136a600. [DOI] [PubMed] [Google Scholar]
  167. Stahl N., Baldwin M. A., Teplow D. B., Hood L., Gibson B. W., Burlingame A. L., Prusiner S. B. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry. 1993 Mar 2;32(8):1991–2002. doi: 10.1021/bi00059a016. [DOI] [PubMed] [Google Scholar]
  168. Stahl N., Borchelt D. R., Hsiao K., Prusiner S. B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell. 1987 Oct 23;51(2):229–240. doi: 10.1016/0092-8674(87)90150-4. [DOI] [PubMed] [Google Scholar]
  169. Tange R. A., Troost D., Limburg M. Progressive fatal dementia (Creutzfeldt-Jakob disease) in a patient who received homograft tissue for tympanic membrane closure. Eur Arch Otorhinolaryngol. 1990;247(4):199–201. doi: 10.1007/BF00178983. [DOI] [PubMed] [Google Scholar]
  170. Taraboulos A., Jendroska K., Serban D., Yang S. L., DeArmond S. J., Prusiner S. B. Regional mapping of prion proteins in brain. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7620–7624. doi: 10.1073/pnas.89.16.7620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Tateishi J., Kitamoto T. Developments in diagnosis for prion diseases. Br Med Bull. 1993 Oct;49(4):971–979. doi: 10.1093/oxfordjournals.bmb.a072656. [DOI] [PubMed] [Google Scholar]
  172. Tateishi J., Ohta M., Koga M., Sato Y., Kuroiwa Y. Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann Neurol. 1979 Jun;5(6):581–584. doi: 10.1002/ana.410050616. [DOI] [PubMed] [Google Scholar]
  173. Taylor D. M., Dickinson A. G., Fraser H., Robertson P. A., Salacinski P. R., Lowry P. J. Preparation of growth hormone free from contamination with unconventional slow viruses. Lancet. 1985 Aug 3;2(8449):260–262. doi: 10.1016/s0140-6736(85)90302-2. [DOI] [PubMed] [Google Scholar]
  174. Thadani V., Penar P. L., Partington J., Kalb R., Janssen R., Schonberger L. B., Rabkin C. S., Prichard J. W. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J Neurosurg. 1988 Nov;69(5):766–769. doi: 10.3171/jns.1988.69.5.0766. [DOI] [PubMed] [Google Scholar]
  175. Tintner R., Brown P., Hedley-Whyte E. T., Rappaport E. B., Piccardo C. P., Gajdusek D. C. Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications. Neurology. 1986 Jul;36(7):932–936. doi: 10.1212/wnl.36.7.932. [DOI] [PubMed] [Google Scholar]
  176. Vnencak-Jones C. L., Phillips J. A., 3rd Identification of heterogeneous PrP gene deletions in controls by detection of allele-specific heteroduplexes (DASH) Am J Hum Genet. 1992 Apr;50(4):871–872. [PMC free article] [PubMed] [Google Scholar]
  177. Weissmann C. A 'unified theory' of prion propagation. Nature. 1991 Aug 22;352(6337):679–683. doi: 10.1038/352679a0. [DOI] [PubMed] [Google Scholar]
  178. Westaway D., DeArmond S. J., Cayetano-Canlas J., Groth D., Foster D., Yang S. L., Torchia M., Carlson G. A., Prusiner S. B. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell. 1994 Jan 14;76(1):117–129. doi: 10.1016/0092-8674(94)90177-5. [DOI] [PubMed] [Google Scholar]
  179. Westaway D., Goodman P. A., Mirenda C. A., McKinley M. P., Carlson G. A., Prusiner S. B. Distinct prion proteins in short and long scrapie incubation period mice. Cell. 1987 Nov 20;51(4):651–662. doi: 10.1016/0092-8674(87)90134-6. [DOI] [PubMed] [Google Scholar]
  180. Westaway D., Mirenda C. A., Foster D., Zebarjadian Y., Scott M., Torchia M., Yang S. L., Serban H., DeArmond S. J., Ebeling C. Paradoxical shortening of scrapie incubation times by expression of prion protein transgenes derived from long incubation period mice. Neuron. 1991 Jul;7(1):59–68. doi: 10.1016/0896-6273(91)90074-a. [DOI] [PubMed] [Google Scholar]
  181. Wilkie A. O., Malcolm S., Pembrey M. E. Isodisomy in BWS chromosomes. Nature. 1991 Oct 31;353(6347):802–802. doi: 10.1038/353802b0. [DOI] [PubMed] [Google Scholar]
  182. Will R. G., Matthews W. B. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 1982 Mar;45(3):235–238. doi: 10.1136/jnnp.45.3.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Willison H. J., Gale A. N., McLaughlin J. E. Creutzfeldt-Jacob disease following cadaveric dura mater graft. J Neurol Neurosurg Psychiatry. 1991 Oct;54(10):940–940. doi: 10.1136/jnnp.54.10.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Ying Y. S., Anderson R. G., Rothberg K. G. Each caveola contains multiple glycosyl-phosphatidylinositol-anchored membrane proteins. Cold Spring Harb Symp Quant Biol. 1992;57:593–604. doi: 10.1101/sqb.1992.057.01.065. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES